A researcher discovered a synthetic material that can perform photosynthesis.» Read More
California may be dry, but water-breeding mosquitoes, and the diseases they carry, still may have another big year in 2015.
Sylvan Learning CEO Jeffrey Cohen and Bill Nye think a new program teaching children robotics could help solve the gender problem in Silicon Valley, with CNBC's Sara Eisen.
Shares of Juno Therapeutics and Kite Pharmaceuticals are falling today based on news coming out of a big cancer conference over the weekend, reports CNBC's Meg Tirrell.
Changes in the prescription drug market may have curbed prescription opioid abuse but may have also fueled a rise in heroin use.
Men seem more inclined toward behaving generously if they see other men doing so—especially when a woman is involved.
Rural thieves in bone-dry California are sacking water pumps and irrigation lines for copper, putting further pressure on farmers.
Avalanche Biotechnologies founder and CEO Thomas Chalberg, discusses treatments for wet macular degeneration, and a potential treatment for color blindness.
Researchers at Stanford University have invented a battery that can fully charge in as little as one minute, with CNBC's Josh Lipton and Phil LeBeau.
CNBC's Meg Tirrell reports the CDC is warning about a drug-resistant illness outbreak called Shigella.
A tipping point may be coming. A crowded marketplace was already pressuring winemakers to cut prices. Now, the drought is pushing up costs.
Think video games are just for fun? Think again. They're part of the future of learning, says UMBC President Freeman Hrabowski.
One week of warm readings may not mean anything, a weather expert says, but it's something to keep an eye to see if it's part of a trend.
Stephen Hawking, the world’s most famous theoretical physicist, has become the latest celebrity to apply for trademark of their name.
Men are growing beards to assert dominance over other men and appeal to women, a report in The Telegraph suggests.
Antarctica may have marked its warmest day ever recorded earlier this week, with a temperature reading of 63.5 F.
Biogen will move its Alzheimer's drug quickly into phase 3 studies, jumping over the middle stage, reports CNBC's Meg Tirrell.
Scientists have found a way to create mutant organisms more reliably using a recently developed gene-editing technique, NBC reports.
In drought-stricken California, farmers make more selling water than rice. NBC News reports.
From vaccines to genetically-modified foods, the scientific community is often stuck playing defense. When did science become a dirty word?
Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.